Dosing is individualized based on response and side effects, often starting at lower doses than those used in transplant patients
Hepatocyte growth factor protects auditory hair cells from aminoglycosides
M1-like macrophages amplify ferroptotic pressure through ferritinophagy-mediated release of labile Fe + , increased transferrin receptor (TfR1) expression, and restricted ferroportin activity, thereby enriching the tumor microenvironment (TME) with redox-active iron (71)
Nausea, vomiting, diarrhoea, constipation, and abdominal pain affect a significant proportion of patients, particularly during dose escalation
GLP-1 receptor agonists carry a boxed warning about thyroid C-cell tumors based on animal studies with liraglutide
Uma Devi et al